These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25623202)

  • 1. Viral hepatitis. HBV cure--can we pin our hopes on immunotherapy?
    Yang HC; Kao JH
    Nat Rev Gastroenterol Hepatol; 2015 Mar; 12(3):129-31. PubMed ID: 25623202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.
    Martin P; Dubois C; Jacquier E; Dion S; Mancini-Bourgine M; Godon O; Kratzer R; Lelu-Santolaria K; Evlachev A; Meritet JF; Schlesinger Y; Villeval D; Strub JM; Van Dorsselaer A; Marchand JB; Geist M; Brandely R; Findeli A; Boukhebza H; Menguy T; Silvestre N; Michel ML; Inchauspé G
    Gut; 2015 Dec; 64(12):1961-71. PubMed ID: 25429051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic vaccination against chronic hepatitis B virus infection.
    Michel ML; Mancini-Bourgine M
    J Clin Virol; 2005 Dec; 34 Suppl 1():S108-14. PubMed ID: 16461209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
    Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
    Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy and therapeutic vaccines for chronic HBV infection.
    Lang-Meli J; Neumann-Haefelin C; Thimme R
    Curr Opin Virol; 2021 Dec; 51():149-157. PubMed ID: 34710645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel therapeutic hepatitis B vaccine induces cellular and humoral immune responses and breaks tolerance in hepatitis B virus (HBV) transgenic mice.
    Buchmann P; Dembek C; Kuklick L; Jäger C; Tedjokusumo R; von Freyend MJ; Drebber U; Janowicz Z; Melber K; Protzer U
    Vaccine; 2013 Feb; 31(8):1197-203. PubMed ID: 23306359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Targeting the Innate and Adaptive Immune Systems to Cure Chronic Hepatitis B Virus Infection.
    Meng Z; Chen Y; Lu M
    Front Immunol; 2019; 10():3127. PubMed ID: 32117201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
    Dou Y; Jansen DTSL; van den Bosch A; de Man RA; van Montfoort N; Araman C; van Kasteren SI; Zom GG; Krebber WJ; Melief CJM; Woltman AM; Buschow SI
    Antiviral Res; 2020 Jun; 178():104746. PubMed ID: 32081741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
    Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
    Godon O; Evlachev A; Bourgine M; Meritet JF; Martin P; Inchauspe G; Michel ML
    Vaccine; 2015 Aug; 33(36):4548-53. PubMed ID: 26209840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
    Han Q; Lan P; Zhang J; Zhang C; Tian Z
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.
    Michel ML; Pol S; Brechot C; Tiollais P
    Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological cure of HBV infection.
    Lang J; Neumann-Haefelin C; Thimme R
    Hepatol Int; 2019 Mar; 13(2):113-124. PubMed ID: 30600480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
    Roggendorf M; Schulte I; Xu Y; Lu M
    J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
    Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
    Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of immune responses induced by therapeutic vaccination with cross-reactive antigens in a humanized hepatitis B surface antigen transgenic mouse model.
    Bourgine M; Dion S; Godon O; Guillen G; Michel ML; Aguilar JC
    Virology; 2012 Aug; 430(1):10-9. PubMed ID: 22591777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic vaccination for treatment of chronic hepatitis B.
    Cargill T; Barnes E
    Clin Exp Immunol; 2021 Aug; 205(2):106-118. PubMed ID: 33969474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic vaccination against chronic hepatitis B virus infection].
    Mancini-Bourgine M; Michel ML
    Therapie; 2005; 60(3):257-65. PubMed ID: 16128268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.